English

PRA Health Sciences, Inc.

EDGAR

PRAH Quarterly report (10-Q) · filed 2021-04-29

54 filing records in this dataset, filed from 2014-09-08 to 2021-04-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

934 million USD

2021 Q1 · USD

Exact inputs and evidence

Revenue: 933775000 USD Source

Operating margin

7.44%

2021 Q1 · %

Exact inputs and evidence

Operating Income: 69508000 USD Source
Revenue: 933775000 USD Source

Operating cash flow

192 million USD

2021 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 192205000 USD Source

Free cash flow

173 million USD

2021 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 192205000 USD Source
Capital Expenditure: 18734000 USD Source

Cash and cash equivalents: 690 million USD 2021-03-31 Source
Exact value

690259000 USD
Long-term debt including current maturities: 1.23 billion USD 2017-12-31 Source
Exact value

1232138000 USD
Shares outstanding: 64.8 million shares 2021-03-31 Source
Exact value

64765369 shares

Reported share-count change

1.79% · 1.14 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

63625742 shares · 2020-03-31· Source
64765369 shares · 2021-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

213 million USD

2020-04-01 – 2021-03-31

Exact inputs and evidence

Net income: 13874000 USD · 2020-04-01 – 2020-06-30 Source
Net income: 91252000 USD · 2020-07-01 – 2020-09-30 Source
Net income: 197043000 USD · 2020-01-01 – 2020-12-31 Source
Net income: 145786000 USD · 2020-01-01 – 2020-09-30 Source
Net income: 56940000 USD · 2021-01-01 – 2021-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2021-04-29.

Financial data available through: 2020-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2020-12-31
Operating income: 6 of 11 periods available· newest 2020-12-31
Net income: 6 of 11 periods available· newest 2020-12-31
Operating cash flow: 6 of 11 periods available· newest 2020-12-31
Capital expenditure: 6 of 11 periods available· newest 2020-12-31
Total assets: 5 of 11 periods available· newest 2020-12-31
Total liabilities: 5 of 11 periods available· newest 2020-12-31
Current assets: 5 of 11 periods available· newest 2020-12-31
Current liabilities: 5 of 11 periods available· newest 2020-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2020-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2017-12-31
Shares outstanding: 5 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.8%

Prior period

USD 3.07 billion

2019-01-01 – 2019-12-31
Current period

USD 3.18 billion

2020-01-01 – 2020-12-31

Exact inputs and evidence

3183365000 − 3066262000 = 117103000 USD

3066262000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
3183365000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Year-over-year change in Revenue: 117103000 USD Concept: fundies:Revenue Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3183365000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#2364955 Filing: 000161385921000011 Input fundies:Revenue: 3066262000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#2366409 Filing: 000161385921000011
The citation records this snapshot. The page link may show a newer release later.
Net income
-18.9%

Prior period

USD 243.02 million

2019-01-01 – 2019-12-31
Current period

USD 197.04 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

197043000 − 243020000 = -45977000 USD

243020000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
197043000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Year-over-year change in Net income: -45977000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 197043000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#958641 Filing: 000161385921000011 Input fundies:NetIncome: 243020000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#959891 Filing: 000161385921000011
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+68.5%

Prior period

USD 253.57 million

2019-01-01 – 2019-12-31
Current period

USD 427.18 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

427178000 − 253567000 = 173611000 USD

253567000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
427178000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Year-over-year change in Operating cash flow: 173611000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 427178000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1220913 Filing: 000161385921000011 Input fundies:OperatingCashFlow: 253567000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1221957 Filing: 000161385921000011
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-10.1%

Prior period

USD 74.29 million

2019-01-01 – 2019-12-31
Current period

USD 66.81 million

2020-01-01 – 2020-12-31

Exact inputs and evidence

66808000 − 74294000 = -7486000 USD

74294000 USD · 2019-01-01 – 2019-12-31
Inspect prior input Prior source
66808000 USD · 2020-01-01 – 2020-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Year-over-year change in Capital expenditure: -7486000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 66808000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1224928 Filing: 000161385921000011 Input fundies:CapitalExpenditure: 74294000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1225909 Filing: 000161385921000011
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

Revenue USD 3.18 billion 100% of revenue
Operating costs Derived USD 2.86 billion 90% of revenue
Operating income USD 328.09 million 10% of revenue
Tax, interest and other Derived USD 131.05 million 4.1% of revenue
Net income USD 197.04 million 6.2% of revenue

Cash

Operating cash flow USD 427.18 million 13% of revenue
Capital expenditure USD 66.81 million 2.1% of revenue
Free cash flow Derived USD 360.37 million 11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 90%
2016 91%
2017 92%
2018 90%
2019 88%
2020 90%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	1613883000	1449585000 Derived	164298000	82533000 Derived	81765000	119614000 Derived	Source 2015-01-01 – 2015-12-31: 1613883000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 164298000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 81765000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 152428000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 32814000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	1811711000	1649362000 Derived	162349000	94174000 Derived	68175000	126904000 Derived	Source 2016-01-01 – 2016-12-31: 1811711000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 162349000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 68175000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 160047000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 33143000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	2259389000	2083164000 Derived	176225000	89298000 Derived	86927000	159090000 Derived	Source 2017-01-01 – 2017-12-31: 2259389000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 176225000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 86927000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 220408000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 61318000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	2871922000	2590610000 Derived	281312000	127407000 Derived	153905000	273912000 Derived	Source 2018-01-01 – 2018-12-31: 2871922000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 281312000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 153905000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 329792000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 55880000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	3066262000	2702337000 Derived	363925000	120905000 Derived	243020000	179273000 Derived	Source 2019-01-01 – 2019-12-31: 3066262000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 363925000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 243020000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 253567000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 74294000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	3183365000	2855276000 Derived	328089000	131046000 Derived	197043000	360370000 Derived	Source 2020-01-01 – 2020-12-31: 3183365000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 328089000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 197043000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 427178000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 66808000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2B 2020

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	1613883000	Revenue: 1613883000 Open source
20162016-12-31	Revenue	1811711000	Revenue: 1811711000 Open source
20172017-12-31	Revenue	2259389000	Revenue: 2259389000 Open source
20182018-12-31	Revenue	2871922000	Revenue: 2871922000 Open source
20192019-12-31	Revenue	3066262000	Revenue: 3066262000 Open source
20202020-12-31	Revenue	3183365000	Revenue: 3183365000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.8% 2020

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 1613883000 Open source
20162016-12-31	Year over year	12.3%	Revenue: 1811711000 Open source Revenue: 1613883000 Open source
20172017-12-31	Year over year	24.7%	Revenue: 2259389000 Open source Revenue: 1811711000 Open source
20182018-12-31	Year over year	27.1%	Revenue: 2871922000 Open source Revenue: 2259389000 Open source
20192019-12-31	Year over year	6.8%	Revenue: 3066262000 Open source Revenue: 2871922000 Open source
20202020-12-31	Year over year	3.8%	Revenue: 3183365000 Open source Revenue: 3066262000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.3% 2020

Net margin 6.2% 2020

Free cash flow margin 11.3% 2020

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	10.2%	Operating Income: 164298000 Open source Revenue: 1613883000 Open source
20162016-12-31	Operating margin	9%	Operating Income: 162349000 Open source Revenue: 1811711000 Open source
20172017-12-31	Operating margin	7.8%	Operating Income: 176225000 Open source Revenue: 2259389000 Open source
20182018-12-31	Operating margin	9.8%	Operating Income: 281312000 Open source Revenue: 2871922000 Open source
20192019-12-31	Operating margin	11.9%	Operating Income: 363925000 Open source Revenue: 3066262000 Open source
20202020-12-31	Operating margin	10.3%	Operating Income: 328089000 Open source Revenue: 3183365000 Open source
20152015-12-31	Net margin	5.1%	Net Income: 81765000 Open source Revenue: 1613883000 Open source
20162016-12-31	Net margin	3.8%	Net Income: 68175000 Open source Revenue: 1811711000 Open source
20172017-12-31	Net margin	3.8%	Net Income: 86927000 Open source Revenue: 2259389000 Open source
20182018-12-31	Net margin	5.4%	Net Income: 153905000 Open source Revenue: 2871922000 Open source
20192019-12-31	Net margin	7.9%	Net Income: 243020000 Open source Revenue: 3066262000 Open source
20202020-12-31	Net margin	6.2%	Net Income: 197043000 Open source Revenue: 3183365000 Open source
20152015-12-31	Free cash flow margin	7.4%	Revenue: 1613883000 Open source Operating Cash Flow: 152428000 Open source Capital Expenditure: 32814000 Open source
20162016-12-31	Free cash flow margin	7%	Revenue: 1811711000 Open source Operating Cash Flow: 160047000 Open source Capital Expenditure: 33143000 Open source
20172017-12-31	Free cash flow margin	7%	Revenue: 2259389000 Open source Operating Cash Flow: 220408000 Open source Capital Expenditure: 61318000 Open source
20182018-12-31	Free cash flow margin	9.5%	Revenue: 2871922000 Open source Operating Cash Flow: 329792000 Open source Capital Expenditure: 55880000 Open source
20192019-12-31	Free cash flow margin	5.8%	Revenue: 3066262000 Open source Operating Cash Flow: 253567000 Open source Capital Expenditure: 74294000 Open source
20202020-12-31	Free cash flow margin	11.3%	Revenue: 3183365000 Open source Operating Cash Flow: 427178000 Open source Capital Expenditure: 66808000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 427.2M 2020

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	152428000	Operating Cash Flow: 152428000 Open source
20162016-12-31	Operating cash flow	160047000	Operating Cash Flow: 160047000 Open source
20172017-12-31	Operating cash flow	220408000	Operating Cash Flow: 220408000 Open source
20182018-12-31	Operating cash flow	329792000	Operating Cash Flow: 329792000 Open source
20192019-12-31	Operating cash flow	253567000	Operating Cash Flow: 253567000 Open source
20202020-12-31	Operating cash flow	427178000	Operating Cash Flow: 427178000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 360.4M 2020

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	119614000	Operating Cash Flow: 152428000 Open source Capital Expenditure: 32814000 Open source
20162016-12-31	Free cash flow	126904000	Operating Cash Flow: 160047000 Open source Capital Expenditure: 33143000 Open source
20172017-12-31	Free cash flow	159090000	Operating Cash Flow: 220408000 Open source Capital Expenditure: 61318000 Open source
20182018-12-31	Free cash flow	273912000	Operating Cash Flow: 329792000 Open source Capital Expenditure: 55880000 Open source
20192019-12-31	Free cash flow	179273000	Operating Cash Flow: 253567000 Open source Capital Expenditure: 74294000 Open source
20202020-12-31	Free cash flow	360370000	Operating Cash Flow: 427178000 Open source Capital Expenditure: 66808000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

64.6% 2020

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
20162016-12-31	Liabilities / assets	66.7%	Total Liabilities: 1461139000 Open source Total Assets: 2190391000 Open source
20172017-12-31	Liabilities / assets	72.1%	Total Liabilities: 2421565000 Open source Total Assets: 3358046000 Open source
20182018-12-31	Liabilities / assets	67%	Total Liabilities: 2135047000 Open source Total Assets: 3186467000 Open source
20192019-12-31	Liabilities / assets	69.2%	Total Liabilities: 2454439000 Open source Total Assets: 3544430000 Open source
20202020-12-31	Liabilities / assets	64.6%	Total Liabilities: 2699316000 Open source Total Assets: 4178501000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.15× 2020

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
20162016-12-31	Current assets / current liabilities	1.11×	Current Assets: 624737000 Open source Current Liabilities: 564199000 Open source
20172017-12-31	Current assets / current liabilities	0.9×	Current Assets: 877024000 Open source Current Liabilities: 971616000 Open source
20182018-12-31	Current assets / current liabilities	0.87×	Current Assets: 782355000 Open source Current Liabilities: 898874000 Open source
20192019-12-31	Current assets / current liabilities	0.97×	Current Assets: 985567000 Open source Current Liabilities: 1017209000 Open source
20202020-12-31	Current assets / current liabilities	1.15×	Current Assets: 1460514000 Open source Current Liabilities: 1266023000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	USD 81.77 million Exact value Exact value: 81765000 USD 2015-01-01 – 2015-12-31: 81765000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRA Health Sciences, Inc. · 2015-12-31 PRA Health Sciences, Inc. (edgar:1613859) Net Income: 81765000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 81765000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/prah-20171231.xml#613799 Filing: 000162828018002026 The citation records this snapshot. The page link may show a newer release later.	USD 152.43 million Exact value Exact value: 152428000 USD 2015-01-01 – 2015-12-31: 152428000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRA Health Sciences, Inc. · 2015-12-31 PRA Health Sciences, Inc. (edgar:1613859) Operating Cash Flow: 152428000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 152428000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/prah-20171231.xml#613043 Filing: 000162828018002026 The citation records this snapshot. The page link may show a newer release later.	USD 32.81 million Exact value Exact value: 32814000 USD 2015-01-01 – 2015-12-31: 32814000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRA Health Sciences, Inc. · 2015-12-31 PRA Health Sciences, Inc. (edgar:1613859) Capital Expenditure: 32814000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 32814000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/prah-20171231.xml#651490 Filing: 000162828018002026 The citation records this snapshot. The page link may show a newer release later.	USD 119.61 million Calculation and evidence 152428000 − 32814000 USD Exact free cash flow: 119614000 USD 2015-01-01 – 2015-12-31: 152428000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 32814000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRA Health Sciences, Inc. · 2015-12-31 PRA Health Sciences, Inc. (edgar:1613859) Free cash flow: 119614000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 152428000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/prah-20171231.xml#613043 Filing: 000162828018002026 Input fundies:CapitalExpenditure: 32814000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/prah-20171231.xml#651490 Filing: 000162828018002026 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 68.18 million Exact value Exact value: 68175000 USD 2016-01-01 – 2016-12-31: 68175000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRA Health Sciences, Inc. · 2016-12-31 PRA Health Sciences, Inc. (edgar:1613859) Net Income: 68175000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 68175000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/q4201810kdocument.htm#1540463 Filing: 000161385919000008 The citation records this snapshot. The page link may show a newer release later.	USD 160.05 million Exact value Exact value: 160047000 USD 2016-01-01 – 2016-12-31: 160047000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRA Health Sciences, Inc. · 2016-12-31 PRA Health Sciences, Inc. (edgar:1613859) Operating Cash Flow: 160047000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 160047000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/q4201810kdocument.htm#1796617 Filing: 000161385919000008 The citation records this snapshot. The page link may show a newer release later.	USD 33.14 million Exact value Exact value: 33143000 USD 2016-01-01 – 2016-12-31: 33143000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRA Health Sciences, Inc. · 2016-12-31 PRA Health Sciences, Inc. (edgar:1613859) Capital Expenditure: 33143000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33143000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/q4201810kdocument.htm#1800914 Filing: 000161385919000008 The citation records this snapshot. The page link may show a newer release later.	USD 126.9 million Calculation and evidence 160047000 − 33143000 USD Exact free cash flow: 126904000 USD 2016-01-01 – 2016-12-31: 160047000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 33143000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRA Health Sciences, Inc. · 2016-12-31 PRA Health Sciences, Inc. (edgar:1613859) Free cash flow: 126904000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 160047000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/q4201810kdocument.htm#1796617 Filing: 000161385919000008 Input fundies:CapitalExpenditure: 33143000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/q4201810kdocument.htm#1800914 Filing: 000161385919000008 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 86.93 million Exact value Exact value: 86927000 USD 2017-01-01 – 2017-12-31: 86927000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRA Health Sciences, Inc. · 2017-12-31 PRA Health Sciences, Inc. (edgar:1613859) Net Income: 86927000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 86927000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/q4201910kdocument.htm#1303475 Filing: 000161385920000007 The citation records this snapshot. The page link may show a newer release later.	USD 220.41 million Exact value Exact value: 220408000 USD 2017-01-01 – 2017-12-31: 220408000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRA Health Sciences, Inc. · 2017-12-31 PRA Health Sciences, Inc. (edgar:1613859) Operating Cash Flow: 220408000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 220408000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/q4201910kdocument.htm#1583374 Filing: 000161385920000007 The citation records this snapshot. The page link may show a newer release later.	USD 61.32 million Exact value Exact value: 61318000 USD 2017-01-01 – 2017-12-31: 61318000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRA Health Sciences, Inc. · 2017-12-31 PRA Health Sciences, Inc. (edgar:1613859) Capital Expenditure: 61318000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 61318000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/q4201910kdocument.htm#1587746 Filing: 000161385920000007 The citation records this snapshot. The page link may show a newer release later.	USD 159.09 million Calculation and evidence 220408000 − 61318000 USD Exact free cash flow: 159090000 USD 2017-01-01 – 2017-12-31: 220408000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 61318000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRA Health Sciences, Inc. · 2017-12-31 PRA Health Sciences, Inc. (edgar:1613859) Free cash flow: 159090000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 220408000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/q4201910kdocument.htm#1583374 Filing: 000161385920000007 Input fundies:CapitalExpenditure: 61318000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/q4201910kdocument.htm#1587746 Filing: 000161385920000007 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 153.91 million Exact value Exact value: 153905000 USD 2018-01-01 – 2018-12-31: 153905000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRA Health Sciences, Inc. · 2018-12-31 PRA Health Sciences, Inc. (edgar:1613859) Net Income: 153905000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 153905000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#961141 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 329.79 million Exact value Exact value: 329792000 USD 2018-01-01 – 2018-12-31: 329792000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRA Health Sciences, Inc. · 2018-12-31 PRA Health Sciences, Inc. (edgar:1613859) Operating Cash Flow: 329792000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 329792000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1223001 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 55.88 million Exact value Exact value: 55880000 USD 2018-01-01 – 2018-12-31: 55880000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRA Health Sciences, Inc. · 2018-12-31 PRA Health Sciences, Inc. (edgar:1613859) Capital Expenditure: 55880000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55880000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1226890 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 273.91 million Calculation and evidence 329792000 − 55880000 USD Exact free cash flow: 273912000 USD 2018-01-01 – 2018-12-31: 329792000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 55880000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRA Health Sciences, Inc. · 2018-12-31 PRA Health Sciences, Inc. (edgar:1613859) Free cash flow: 273912000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 329792000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1223001 Filing: 000161385921000011 Input fundies:CapitalExpenditure: 55880000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1226890 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 243.02 million Exact value Exact value: 243020000 USD 2019-01-01 – 2019-12-31: 243020000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRA Health Sciences, Inc. · 2019-12-31 PRA Health Sciences, Inc. (edgar:1613859) Net Income: 243020000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 243020000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#959891 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 253.57 million Exact value Exact value: 253567000 USD 2019-01-01 – 2019-12-31: 253567000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRA Health Sciences, Inc. · 2019-12-31 PRA Health Sciences, Inc. (edgar:1613859) Operating Cash Flow: 253567000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 253567000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1221957 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 74.29 million Exact value Exact value: 74294000 USD 2019-01-01 – 2019-12-31: 74294000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRA Health Sciences, Inc. · 2019-12-31 PRA Health Sciences, Inc. (edgar:1613859) Capital Expenditure: 74294000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74294000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1225909 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 179.27 million Calculation and evidence 253567000 − 74294000 USD Exact free cash flow: 179273000 USD 2019-01-01 – 2019-12-31: 253567000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 74294000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRA Health Sciences, Inc. · 2019-12-31 PRA Health Sciences, Inc. (edgar:1613859) Free cash flow: 179273000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 253567000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1221957 Filing: 000161385921000011 Input fundies:CapitalExpenditure: 74294000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1225909 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 197.04 million Exact value Exact value: 197043000 USD 2020-01-01 – 2020-12-31: 197043000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Net Income: 197043000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 197043000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#958641 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 427.18 million Exact value Exact value: 427178000 USD 2020-01-01 – 2020-12-31: 427178000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Operating Cash Flow: 427178000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 427178000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1220913 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 66.81 million Exact value Exact value: 66808000 USD 2020-01-01 – 2020-12-31: 66808000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Capital Expenditure: 66808000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 66808000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1224928 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.	USD 360.37 million Calculation and evidence 427178000 − 66808000 USD Exact free cash flow: 360370000 USD 2020-01-01 – 2020-12-31: 427178000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 66808000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRA Health Sciences, Inc. · 2020-12-31 PRA Health Sciences, Inc. (edgar:1613859) Free cash flow: 360370000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1613859?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 427178000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1220913 Filing: 000161385921000011 Input fundies:CapitalExpenditure: 66808000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1613859/000161385921000011/prah-20201231.htm#1224928 Filing: 000161385921000011 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

54 filings · 3,625 latest values · 3,625 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001613859, 1613859, PRAH, edgar:1613859

Also known as PRA Health Sciences, Inc., PRA Health Sciences, Inc.

PRA Health Sciences, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2020 2020-01-01 – 2020-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation